Investigating ocular ischemic events following pars plana vitrectomy.

Area of Science:

• Ophthalmology
• Vascular Surgery
• Public Health

Background:

• Vitrectomy is a common surgical procedure for various retinal conditions.
• Ocular ischemic events are serious complications that can affect vision.
• Understanding the risk of these events post-vitrectomy is crucial for patient management.

Purpose of the Study:

• To determine the incidence of post-vitrectomy ocular ischemic events.
• To assess the specific risks of retinal artery occlusion (RAO), retinal vein occlusion (RVO), and non-arteritic ischemic optic neuropathy (NAION).
• To compare the risk associated with vitrectomy against other clinical factors.

Main Methods:

• Retrospective cohort study of 120,350 patients undergoing vitrectomy.
• Analysis of a multicenter healthcare database using CPT codes for vitrectomy.
• Follow-up analysis of 510,915 patients to evaluate vitrectomy risk versus clinical characteristics.
• Exclusion of patients with prior ocular ischemic events or less than six months follow-up.

Main Results:

• The first post-operative month showed significantly higher risks: IRR 9.69 for RAO, 11.43 for RVO, and 8.75 for NAION.
• Overall ischemic events were elevated in the first month (IRR 10.7) and remained higher up to six months (IRR 1.49).
• Vitrectomy was the strongest correlated factor for ischemic events (HR 3.32) compared to cataract surgery or nicotine use.

Conclusions:

• Vitrectomy is associated with a substantially increased risk of ocular ischemic events.
• The highest risk occurs within the first month after surgery.
• The risk diminishes over time but remains elevated for up to six months post-vitrectomy.